Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
July 14, 2009
Patent Application Number
10513437
Date Filed
May 7, 2003
Patent Citations Received
Patent Primary Examiner
Patent abstract
Good bioavailability of desmopressin can be obtained by means of an orodispersible pharmaceutical dosage form. Preferred dosage forms comprise desmopressin and an open matrix network which is an inert water-soluble or water-dispersible carrier material. Desmopressin formulated in this way is useful for voiding postponement, or the treatment or prevention of incontinence, primary nocturnal enuresis (PNE), nocturia or central diabetes insipidus. Peptides other than desmopressin can also be formulated in this way.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.